Literature DB >> 2351926

Osteoporosis after long-term corticosteroid treatment of giant cell arteritis.

R Andersson1, A Rundgren, K Rosengren, B A Bengtsson, B E Malmvall, D Mellström.   

Abstract

The mineral content of the heel bone, and signs of osteoporosis on X-ray of the spine, were evaluated in 26 patients (20 women and 6 men) with giant cell arteritis (GCA), treated with prednisolone for an average period of 5 years. The mean age was 78 years (range 66-95 years). These results were compared with those obtained from a large population study of individuals aged 72, 75, 82 and 85 years. An increase of obvious and severe spinal osteoporosis from 16 to 85% was observed in the women in the population study between the ages of 72 and 85. No additional osteoporosis that could be attributed to the cortisone treatment was found among the GCA patients. The bone mineral content was not reduced in the patients compared to the general population. We conclude that there is no justification for attempting non-steroid treatment in GCA on account of the risk of osteoporosis. Corticosteroids are the only safe treatment for prevention of complications of GCA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351926     DOI: 10.1111/j.1365-2796.1990.tb00177.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Clinical utilities of quantitative ultrasound in osteoporosis associated with inflammatory rheumatic diseases.

Authors:  Win Min Oo; Vasikaran Naganathan; Myat Thae Bo; David J Hunter
Journal:  Quant Imaging Med Surg       Date:  2018-02

Review 2.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 3.  Giant cell arteritis. Epidemiology and treatment.

Authors:  E Nordborg; R Andersson; B A Bengtsson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 4.  Glucocorticoid-induced osteoporosis in rheumatic diseases.

Authors:  Rosa Maria Rodrigues Pereira; Jozélio Freire de Carvalho; Ernesto Canalis
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis.

Authors:  E Nordborg; T Hansson; R Jonson; J Szücs; B A Bengtsson
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

6.  A controlled study of bone mineral density in patients with inflammatory bowel disease.

Authors:  J A Silvennoinen; T J Karttunen; S E Niemelä; J J Manelius; J K Lehtola
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

Review 7.  The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides.

Authors:  Christopher David Box; Owen Cronin; Barbara Hauser
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.